Cost of remicade?

Remicade (infliximab) cost isn’t fixed. It depends on country, whether you’re using the brand or a biosimilar, your dose, how often you get infusions, and your insurance or subsidy. Here’s a quick overview to help you estimate:

- In the U.S., patient out-of-pocket can vary widely. A single infusion can cost several thousand dollars, and an induction course (the first few infusions) often runs significantly higher. The annual therapy cost can range widely—from tens of thousands to more than a hundred thousand dollars—depending on dose and how often you receive infusions.
- Biosimilars are available (for example, Inflectra and Renflexis) and can be cheaper than the brand; costs can be notably lower, but this depends on your insurer and pharmacy.
- For people with insurance, your copay or coinsurance will depend on your plan, deductible status, and whether your plan requires prior authorization.

Ways to get a precise number for you:
- Check with your infusion center or pharmacist for a cost estimate based on your weight, dose, and infusion schedule.
- Contact your insurer or the plan’s member services to understand coverage, allowed amount, and out-of-pocket costs for Remicade vs a biosimilar.
- Ask Janssen CarePath or the biosimilar manufacturers about patient assistance programs and cost estimates.
- If you’re uninsured or underinsured, request information on any patient assistance programs or timelines for applying.

If you tell me your country, whether you’re considering Remicade or a biosimilar, and your approximate weight (for dose estimation), I can give a rough range and list the likely cost drivers for your situation.